secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0001493152-25-013046
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucid Diagnostics closes $28.75M public offering of 28.75M shares at $1.00/share
--------------------------------------------------------------------------------

- Closed underwritten public offering of 28,750,000 shares at $1.00 per share, including full exercise of underwriters' option for 3,750,000 additional shares.
- Net proceeds expected to be approximately $26.9 million after deducting underwriting discounts and offering expenses.
- Proceeds will be used for working capital and general corporate purposes.
- Canaccord Genuity and BTIG acted as joint bookrunners; Maxim Group LLC served as co-manager.
- Offering made under existing effective shelf registration statement (Form S-3, File No. 333-268560).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315225013046/0001493152-25-013046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315225013046/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer